BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Devarakonda S, Efebera Y, Sharma N. Role of Stem Cell Transplantation in Multiple Myeloma. Cancers (Basel) 2021;13:863. [PMID: 33670709 DOI: 10.3390/cancers13040863] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Devarakonda S, Sharma N, Efebera Y. The first relapse in multiple myeloma: how to pick the next best thing. Hematology Am Soc Hematol Educ Program 2022;2022:560-8. [PMID: 36485087 DOI: 10.1182/hematology.2022000356] [Reference Citation Analysis]
2 Du J, Zhuang J. Major advances in the treatment of multiple myeloma in American Society of Hematology annual meeting 2020. Chronic Dis Transl Med 2021;7:220-6. [PMID: 34786541 DOI: 10.1016/j.cdtm.2021.08.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wang H, Yu D, Zhang H, Ma R, Wu H, Zhai H, Wang H, Li J, Li L, Wang Y, Cheng T, Shi J. Quercetin inhibits the proliferation of multiple myeloma cells by upregulating PTPRR expression. Acta Biochim Biophys Sin (Shanghai) 2021;53:1505-15. [PMID: 34558606 DOI: 10.1093/abbs/gmab128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Morabito F, Tripepi G, Martino EA, Vigna E, Mendicino F, Morabito L, Todoerti K, Al-Janazreh H, D'Arrigo G, Canale FA, Cutrona G, Neri A, Martino M, Gentile M. Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma. Drug Des Devel Ther 2021;15:2969-78. [PMID: 34262262 DOI: 10.2147/DDDT.S295215] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
5 Kobold S. Wirksamkeit von Anti-BCMA-CAR-T-Zellen. InFo Hämatol Onkol 2021;24:28-29. [DOI: 10.1007/s15004-021-8660-4] [Reference Citation Analysis]